老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

AbCellera Biologics

12.64
+0.09000.72%
盘后：12.45-0.1850-1.46%19:59 EDT
成交量：575.63万
成交额：7,329.79万
市值：40.94亿
市盈率：-23.16
高：13.06
开：12.71
低：12.43
收：12.55
52周最高：15.02
52周最低：2.75
股本：3.24亿
流通股本：2.21亿
量比：0.90
换手率：2.60%
股息：- -
股息率：- -
每股收益(TTM):-0.5455
每股收益(LYR):-0.4902
净资产收益率：-17.30%
总资产收益率：-10.39%
市净率：4.57
市盈率(LYR):-25.78

数据加载中...

总览公司新闻资讯公告
2021/06/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/10

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/05/17

重要事件披露

8-K/A [Amend] - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/01

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/29

重要事件披露

8-K - Current report
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/28

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多